Skip to content

Clinical trials

Phase 3 Lymphoma, Mantle-Cell trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Mantle-Cell Phase: Phase 3 Country / region: Australia Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20101
20132
20172
20191
20211
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting4
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BeOne Medicines2
Janssen Research & Development, LLC2
Acerta Pharma BV1
Baxalta now part of Shire1
Cephalon1
Loxo Oncology, Inc.1
Pharmacyclics LLC.1
Teva Branded Pharmaceutical Products R&D, Inc.1
The Canadian Blood and Marrow Transplant Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Mantle-Cell11
Lymphoma, Non-Hodgkin8
Leukemia, Lymphocytic, Chronic, B-Cell3
Lymphoma3
Lymphoma, Follicular3
Lymphoma, Large B-Cell, Diffuse3
Burkitt Lymphoma2
Graft vs Host Disease2
Hodgkin Disease2
Leukemia2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.